These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23187835)

  • 21. Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project.
    Iacobuzio-Donahue CA
    Gut; 2012 Jul; 61(7):1085-94. PubMed ID: 21749982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic progression of pancreatic cancer.
    Cowan RW; Maitra A
    Cancer J; 2014; 20(1):80-4. PubMed ID: 24445769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities.
    Lüttges J; Klöppel G
    Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer.
    Hong SM; Vincent A; Kanda M; Leclerc J; Omura N; Borges M; Klein AP; Canto MI; Hruban RH; Goggins M
    Clin Cancer Res; 2012 Aug; 18(16):4303-12. PubMed ID: 22723370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma.
    Hanlon L; Avila JL; Demarest RM; Troutman S; Allen M; Ratti F; Rustgi AK; Stanger BZ; Radtke F; Adsay V; Long F; Capobianco AJ; Kissil JL
    Cancer Res; 2010 Jun; 70(11):4280-6. PubMed ID: 20484026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Diagnostics in the Evaluation of Pancreatic Cysts.
    Theisen BK; Wald AI; Singhi AD
    Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing.
    Iacobuzio-Donahue CA; Velculescu VE; Wolfgang CL; Hruban RH
    Clin Cancer Res; 2012 Aug; 18(16):4257-65. PubMed ID: 22896692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular alterations in pancreatic tumors.
    Visani M; Acquaviva G; De Leo A; Sanza V; Merlo L; Maloberti T; Brandes AA; Franceschi E; Di Battista M; Masetti M; Jovine E; Fiorino S; Pession A; Tallini G; de Biase D
    World J Gastroenterol; 2021 Jun; 27(21):2710-2726. PubMed ID: 34135550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pancreatic acinar neoplasms : Comparative molecular characterization].
    Bergmann F
    Pathologe; 2016 Nov; 37(Suppl 2):191-195. PubMed ID: 27807633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into pancreatic cancer biology.
    Hidalgo M
    Ann Oncol; 2012 Sep; 23 Suppl 10():x135-8. PubMed ID: 22987949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.
    Tulla KA; Maker AV
    Langenbecks Arch Surg; 2018 Mar; 403(2):151-194. PubMed ID: 29218397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathology of pancreatic cancer.
    Hruban RH; Iacobuzio-Donahue C; Wilentz RE; Goggins M; Kern SE
    Cancer J; 2001; 7(4):251-8. PubMed ID: 11561601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
    Nakamoto M; Hisaoka M
    J UOEH; 2016 Mar; 38(1):1-8. PubMed ID: 26972939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.
    Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T
    Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
    Chandana S; Mahadevan D
    Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of Familial and Sporadic Pancreatic Cancer.
    Wood LD; Yurgelun MB; Goggins MG
    Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic carcinogenesis.
    Koorstra JB; Hustinx SR; Offerhaus GJ; Maitra A
    Pancreatology; 2008; 8(2):110-25. PubMed ID: 18382097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
    Dunne RF; Hezel AF
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular signatures of pancreatic cancer.
    Hong SM; Park JY; Hruban RH; Goggins M
    Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer: A suppression switch.
    Starobinets H; Debnath J
    Nature; 2013 Dec; 504(7479):225-6. PubMed ID: 24305045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.